logo

For the Inventor, By the Inventor

Pisa, Italy

Claudio Farina

This inventor holds 5 USPTO granted patents, plus 5 CIPO patents and 7 EPO patents. Top assignee: Kedrion S.p.a.. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudio Farina. Retrieved from https://idiyas.com/inventor/claudio-farina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:

goldMedal5 out of 5 
 
Kedrion S.p.a.
 patents

Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 11591587 - Process for plasminogen purification starting from human plasma (2023-02-28),
2. 9422361 - Process for highly selective purification of two plasma proteins: von willebrand factor (vWF) and fibronectin (Fn) (2016-08-23),
3. 9138454 - Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases (2015-09-22),
4. 8933204 - Process for the industrial-scale purification of gamma globulins from human plasma for industrial applications (2015-01-13),
5. 8822643 - Process for the preparation of a virus-inactivated FV concentrate starting from human plasma, scalable to industrial level (2014-09-02),

Title: Claudio Farina: Innovator in Plasma Protein Purification

Introduction

Claudio Farina is a notable inventor based in Pisa, Italy. He has made significant contributions to the field of biochemistry, particularly in the purification of plasma proteins. With a total of 5 patents, his work has the potential to impact therapeutic applications for human diseases.

Latest Patents

One of his latest patents is a process for plasminogen purification starting from human plasma. This invention outlines a method that includes virus inactivation, a single affinity chromatographic step, and a virus removal nanofiltration step. The process is scalable to an industrial level and produces a functional and intact finished product suitable for treating genetic plasminogen deficiency. Another significant patent involves the highly selective purification of two plasma proteins: von Willebrand factor (vWF) and fibronectin (Fn). This chromatographic purification process allows for the extraction of highly purified vWF and Fn from a biological fraction enriched in these proteins, making it particularly suitable for therapeutic use.

Career Highlights

Claudio Farina is currently associated with Kedrion S.p.a., a company known for its expertise in the biopharmaceutical sector. His work at Kedrion has been instrumental in advancing purification techniques that are crucial for developing effective treatments.

Collaborations

He collaborates with talented coworkers, including Claudia Nardini and Ester Ascione, who contribute to the innovative environment at Kedrion.

Conclusion

Claudio Farina's contributions to plasma protein purification exemplify the intersection of innovation and healthcare. His patents not only enhance the understanding of protein purification but also pave the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…